Private · Company · Aksjeselskap
Eurofins Biopharma Product Testing Norway AS
931 468 065 ↗Research and experimental development on natural sciences and engineering · NACE 72.100Moss
↳ Brreg · companies
MoneyNOK
Revenue
kr 889k
Operating result
kr 470k
Net result
kr 379k
Total assets
kr 1.22M
Equity
kr 696k
FY2025 kr 889k vs FY2024 kr 1.22M · -27% revenue
Regnskapsregisteret · company_financials · FY2025 (company)
Group financialsNOK
- Revenue
- Net profit
| FY24 | FY25 | |
|---|---|---|
| Revenue | 1.22M | 889k |
| Net profit | 348k | 379k |
Regnskapsregisteret · company_revenue
Key figuresBrønnøysund
FY24FY25TREND
Revenue1225k889k
Operating result452k470k
Net result348k379k
Regnskapsregisteret · company_revenue
From the FY2025 accounts
FILEDAccounts filed for FY2025.
AUDITAudited by CEDRA NORGE AS.
BALANCEEquity kr 696k.
Regnskapsregisteret + Brreg roles · the annual-report PDF is a paid Brønnøysund document, so these are the filed facts, not extracted prose